Factors associated with readmissions in women participating in screening programs and treated for breast cancer: a retrospective cohort study

Table 2 Treatments provided according to readmission

	Readmitted, n (%)			Not readmitted, n (%) (n = 821)	p-value¹
	Early readmission (n = 76)	Late readmission (n = 87)	Long-term readmission (n = 71)	Not readmitted, n (%) (n = 821)	p-value¹
Neoadjuvant therapy
No	72 (94.7)^a	80 (92.0)^b	52 (73.2)^a,b,c	731 (89.1)^c	< 0.001
Yes	4 (5.3)^a	7 (8.0)^b	19 (26.8) ^a,b,c	89 (10.9)^c	< 0.001
Missing	0	0	0	1
Surgical treatment
Conservative² surgery without lymphadenectomy	30 (40.5)^a	30 (34.9)^b	10 (14.5) ^a,b,c	267 (32.8)^c	0.001
Conservative² surgery with lymphadenectomy	27 (36.5)	40 (46.5)	31 (44.9)	386 (47.4)
Radical³ surgery with or without lymphadenectomy	17 (23.0)	13 (15.1)^a	25 (36.2) ^a,b	149 (18.3)^b
No surgery and/or adjuvant treatment	0 (0.0)	3 (3.5)	3 (4.3)	12 (1.5)
Missing	2	1	2	7
Adjuvant treatment post-surgery
Chemotherapy, radiotherapy and hormone therapy with/without anti-Her2 therapy	30 (39.5)	28 (32.2)	20 (29.0)	229 (28.1)	0.159
Radiotherapy and hormone therapy with/without anti-Her2 therapy	14 (18.4)	27 (31.0)	22 (31.9)	288 (35.4)
Radiotherapy and chemotherapy with/without anti-Her2 therapy	9 (11.8)	5 (5.7)	9 (13.0)	71 (8.7)
Other treatments	23 (30.3)	27 (31.0)	18 (26.1)	226 (27.8)
Missing	0	0	2	7

¹ Chi-square test
² Included: quadrantectomy, tumorectomy and segmentectomy
³ Included: simple mastectomy, radical mastectomy, and modified radical mastectomy
^a,b,c Values in the same row and subtable sharing the same subscript were significantly different (p < .05) in the two-sided equality test for column proportions

ISSN: 1472-6963